MARC HOROWITZ to Doxorubicin
This is a "connection" page, showing publications MARC HOROWITZ has written about Doxorubicin.
Connection Strength
0.176
-
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol. 1996 Feb; 14(2):362-72.
Score: 0.116
-
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer. 1996 Aug 15; 78(4):901-11.
Score: 0.030
-
Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcoma. J Natl Cancer Inst. 1991 Oct 16; 83(20):1460-70.
Score: 0.022
-
The impact of delayed surgery on radiotherapy dose and local control of rhabdomyosarcoma. Arch Surg. 1987 Dec; 122(12):1451-4.
Score: 0.004
-
Combination of dacarbazine and doxorubicin in the treatment of childhood rhabdomyosarcoma. Cancer Treat Rep. 1985 Sep; 69(9):999-1000.
Score: 0.004